Cargando…

Genetic Risk for Schizophrenia and Psychosis in Alzheimer Disease

Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent in Alzheimer Disease, affecting ~ 40% to 60% of individuals with AD (AD with psychosis, AD+P). In comparison to AD subjects without psychosis, AD+P subjects have more rapid cognitive decline and poor outcomes....

Descripción completa

Detalles Bibliográficos
Autores principales:	DeMichele-Sweet, Mary Ann A., Weamer, Elise A., Klei, Lambertus, Vrana, Dylan T., Hollingshead, Deborah J., Seltman, Howard J., Sims, Rebecca, Foroud, Tatiana, Hernandez, Isabel, Moreno-Grau, Sonia, Tárraga, Lluís, Boada, Mercè, Ruiz, Agustin, Williams, Julie, Mayeux, Richard, Lopez, Oscar L., Sibille, Etienne L., Kamboh, M. Ilyas, Devlin, Bernie, Sweet, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668212/ https://www.ncbi.nlm.nih.gov/pubmed/28461698 http://dx.doi.org/10.1038/mp.2017.81

Ejemplares similares

Genome-Wide Association Identifies the First Risk Loci for Psychosis in Alzheimer Disease
por: DeMichele-Sweet, Mary Ann A., et al.
Publicado: (2021)

Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype
por: Christie, Drew, et al.
Publicado: (2012)

Psychosis in Alzheimer's Disease in the National Alzheimer's Disease Coordinating Center Uniform Data Set: Clinical Correlates and Association with Apolipoprotein E
por: DeMichele-Sweet, Mary Ann A., et al.
Publicado: (2011)

Schizophrenia-associated differential DNA methylation in brain is distributed across the genome and annotated to MAD1L1, a locus at which DNA methylation and transcription phenotypes share genetic variation with schizophrenia risk
por: McKinney, Brandon C., et al.
Publicado: (2022)

Semisoft clustering of single-cell data
por: Zhu, Lingxue, et al.
Publicado: (2019)

O11.1. MULTIPLE GENOMIC MEASURES OF SCHIZOPHRENIA RISK ARE RELATED TO CORTICAL THICKNESS IN TYPICALLY DEVELOPING YOUTH AND YOUNG ADULTS
por: Jalbrzikowski, Maria, et al.
Publicado: (2020)

A Rare Duplication on Chromosome 16p11.2 Is Identified in Patients with Psychosis in Alzheimer's Disease
por: Zheng, Xiaojing, et al.
Publicado: (2014)

Genome-wide copy-number variation study of psychosis in Alzheimer's disease
por: Zheng, X, et al.
Publicado: (2015)

Amino Acid Position 11 of HLA-DRβ1 is a Major Determinant of Chromosome 6p Association with Ulcerative Colitis
por: Achkar, Jean-Paul, et al.
Publicado: (2011)

Functional connectome fingerprinting accuracy in youths and adults is similar when examined on the same day and 1.5‐years apart
por: Jalbrzikowski, Maria, et al.
Publicado: (2020)

Psychosis in Alzheimer’s Disease
por: Ballard, Clive, et al.
Publicado: (2020)

Association between cell-bound blood amyloid-β(1–40) levels and hippocampus volume
por: Sotolongo-Grau, Oscar, et al.
Publicado: (2014)

Transcriptome alterations are enriched for synapse-associated genes in the striatum of subjects with obsessive-compulsive disorder
por: Piantadosi, Sean C., et al.
Publicado: (2021)

Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old
por: Alegret, Montserrat, et al.
Publicado: (2013)

Correction: Cut-off Scores of a Brief Neuropsychological Battery (NBACE) for Spanish Individual Adults Older than 44 Years Old
por: Alegret, Montserrat, et al.
Publicado: (2014)

Network Systems Pharmacology-Based Mechanism Study on the Beneficial Effects of Vitamin D against Psychosis in Alzheimer’s Disease
por: Fan, Peihao, et al.
Publicado: (2020)

Comparison of gene expression in living and postmortem human brain
por: Collado-Torres, Leonardo, et al.
Publicado: (2023)

Reliable Measurements of the β-Amyloid Pool in Blood Could Help in the Early Diagnosis of AD
por: Pesini, Pedro, et al.
Publicado: (2012)

Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
por: Ruiz, Agustín, et al.
Publicado: (2013)

Correction: Blood Amyloid Beta Levels in Healthy, Mild Cognitive Impairment and Alzheimer’s Disease Individuals: Replication of Diastolic Blood Pressure Correlations and Analysis of Critical Covariates
por: Ruiz, Agustín, et al.
Publicado: (2014)

Combination of antidepressants and antipsychotics as a novel treatment option for psychosis in Alzheimer's disease
por: Fan, Peihao, et al.
Publicado: (2023)

Fingolimod mitigates synaptic deficits and psychosis‐like behavior in APP/PSEN1 mice
por: Krivinko, Josh M., et al.
Publicado: (2022)

Thomas Harriot's artis analyticae praxis: an english translation with commentary
por: Seltman, Muriel, et al.
Publicado: (2007)

Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer’s Disease Research
por: Boada, Mercè, et al.
Publicado: (2018)

Heritable Variation, With Little or No Maternal Effect, Accounts for Recurrence Risk to Autism Spectrum Disorder in Sweden
por: Yip, Benjamin Hon Kei, et al.
Publicado: (2017)

Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study
por: Pérez-Grijalba, Virginia, et al.
Publicado: (2019)

A Brief Synopsis on the Genetics of Alzheimer’s Disease
por: Kamboh, M. Ilyas
Publicado: (2018)

Genomics and Functional Genomics of Alzheimer’s Disease
por: Kamboh, M. Ilyas
Publicado: (2021)

Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline
por: Pascual-Lucas, María, et al.
Publicado: (2023)

Cognitive and Neuropsychiatric Manifestations of COVID-19 and Effects on Elderly Individuals With Dementia
por: Alonso-Lana, Silvia, et al.
Publicado: (2020)

Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease
por: Hu, Ziheng, et al.
Publicado: (2018)

The MAPT H1 Haplotype Is a Risk Factor for Alzheimer’s Disease in APOE ε4 Non-carriers
por: Sánchez-Juan, Pascual, et al.
Publicado: (2019)

Targeting the post-synaptic proteome has therapeutic potential for psychosis in Alzheimer Disease
por: Krivinko, J. M., et al.
Publicado: (2023)

Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer’s Disease: Towards a Personalized Polypharmacology Patient-Centered Approach
por: Morató, Xavier, et al.
Publicado: (2022)

Identification of undiagnosed dementia cases using a web‐based pre‐screening tool: The MOPEAD project
por: Rodrigo, Adrián, et al.
Publicado: (2021)

The National Institute on Aging Late‐Onset Alzheimer's Disease Family Based Study: A resource for genetic discovery
por: Reyes‐Dumeyer, Dolly, et al.
Publicado: (2022)

Personality Factors and Subjective Cognitive Decline: The FACEHBI Cohort
por: Muñoz, Nathalia, et al.
Publicado: (2020)

Population-Based Resequencing of LIPG and ZNF202 Genes in Subjects with Extreme HDL Levels
por: Razzaghi, Hamid, et al.
Publicado: (2012)

Genome-wide significant risk factors on chromosome 19 and the APOE locus
por: Moreno-Grau, Sonia, et al.
Publicado: (2018)

Late-Onset Alzheimer’s Disease Genes and the Potentially Implicated Pathways
por: Rosenthal, Samantha L., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a97vnj8rhgb7gn3rvjedqra6bi